Antiviral therapy (pegylated interferon and ribavirin) of hepatitis C in dialysis patients: meta-analysis of clinical studies

Efficacy and Safety of Pegylated Interferon Alfa-2b and Ribavirin Combination Therapy Versus Pegylated Interferon Monotherapy in Hemodialysis Patients: A Comparison of 2 Sequentially Treated Cohorts

(2013) Po-Lin Tseng et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Hepatitis C Infection Is Very Rarely Treated among Hemodialysis Patients

(2013) David A. Goodkin et al.   AMERICAN JOURNAL OF NEPHROLOGY

Pegylated Interferon-α2a With or Without Low-Dose Ribavirin for Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Receiving Hemodialysis

(2013) Chen-Hua Liu et al.   ANNALS OF INTERNAL MEDICINE

Cardiovascular diseases and HCV infection: a simple association or more?

(2013) Salvatore Petta et al.   GUT

Treatment of chronic hepatitis C with peginterferon alfa-2b, plus ribavirin in end stage renal disease patients treated by hemodialysis: single Saudi center experience

(2013) Khalid Alsaran et al.   RENAL FAILURE

Anti-viral triple therapy with telaprevir in haemodialysed HCV patients: Is it feasible?

(2012) Jérôme Dumortier et al.   JOURNAL OF CLINICAL VIROLOGY

Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality?

(2012) F. Fabrizi et al.   JOURNAL OF VIRAL HEPATITIS

Anti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy

(2011) P. Deltenre et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Full-Dose Peginterferon Alfa-2a and Low-Dose Ribavirin Treatment of Genotypes 1 and 4 Chronic Hepatitis CPatients With End-Stage Renal Disease

(2011) Mamdouh M. Abdulhadi–Ali et al.   Clinical Gastroenterology and Hepatology

Treatment of hepatitis C virus infection in patients on maintenance hemodialysis: A single United Arab Emirates center experience

(2011) A. Giguere et al.   European Journal of Internal Medicine

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

(2010) Paul Y Kwo et al.   LANCET

HCV Response in Patients With End Stage Renal Disease Treated With Combination Pegylated Interferon α-2a and Ribavirin

(2009) Wyel Hakim et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection

(2009) Christophe Hézode et al.   NEW ENGLAND JOURNAL OF MEDICINE

Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection

(2009) John G. McHutchison et al.   NEW ENGLAND JOURNAL OF MEDICINE